241 related articles for article (PubMed ID: 19643727)
1. Intrinsic pathway of apoptosis in peripheral blood eosinophils of Churg-Strauss syndrome.
Jakiela B; Szczeklik W; Sokolowska B; Mastalerz L; Sanak M; Plutecka H; Szczeklik A
Rheumatology (Oxford); 2009 Oct; 48(10):1202-7. PubMed ID: 19643727
[TBL] [Abstract][Full Text] [Related]
2. Eotaxin-3 is involved in Churg-Strauss syndrome--a serum marker closely correlating with disease activity.
Polzer K; Karonitsch T; Neumann T; Eger G; Haberler C; Soleiman A; Hellmich B; Csernok E; Distler J; Manger B; Redlich K; Schett G; Zwerina J
Rheumatology (Oxford); 2008 Jun; 47(6):804-8. PubMed ID: 18397958
[TBL] [Abstract][Full Text] [Related]
3. Serum eosinophil cationic protein: a marker of disease activity in Churg-Strauss syndrome.
Guilpain P; Auclair JF; Tamby MC; Servettaz A; Mahr A; Weill B; Guillevin L; Mouthon L
Ann N Y Acad Sci; 2007 Jun; 1107():392-9. PubMed ID: 17804567
[TBL] [Abstract][Full Text] [Related]
4. Increased serum high mobility group box-1 level in Churg-Strauss syndrome.
Taira T; Matsuyama W; Mitsuyama H; Kawahara KI; Higashimoto I; Maruyama I; Osame M; Arimura K
Clin Exp Immunol; 2007 May; 148(2):241-7. PubMed ID: 17437420
[TBL] [Abstract][Full Text] [Related]
5. Increased production of IL-5 and dominant Th2-type response in airways of Churg-Strauss syndrome patients.
Jakiela B; Szczeklik W; Plutecka H; Sokolowska B; Mastalerz L; Sanak M; Bazan-Socha S; Szczeklik A; Musial J
Rheumatology (Oxford); 2012 Oct; 51(10):1887-93. PubMed ID: 22772323
[TBL] [Abstract][Full Text] [Related]
6. Involvement of regulatory T cells in the pathogenesis of Churg-Strauss syndrome.
Saito H; Tsurikisawa N; Tsuburai T; Akiyama K
Int Arch Allergy Immunol; 2008; 146 Suppl 1():73-6. PubMed ID: 18504411
[TBL] [Abstract][Full Text] [Related]
7. Differences in regulatory T cells between Churg-Strauss syndrome and chronic eosinophilic pneumonia with asthma.
Tsurikisawa N; Saito H; Tsuburai T; Oshikata C; Ono E; Mitomi H; Akiyama K
J Allergy Clin Immunol; 2008 Sep; 122(3):610-6. PubMed ID: 18586318
[TBL] [Abstract][Full Text] [Related]
8. Proinflammatory cytokines and autoimmunity in Churg-Strauss syndrome.
Hellmich B; Csernok E; Gross WL
Ann N Y Acad Sci; 2005 Jun; 1051():121-31. PubMed ID: 16126951
[TBL] [Abstract][Full Text] [Related]
9. Both Th2 and Th17 responses are involved in the pathogenesis of Churg-Strauss syndrome.
Jakiela B; Sanak M; Szczeklik W; Sokolowska B; Plutecka H; Mastalerz L; Musial J; Szczeklik A
Clin Exp Rheumatol; 2011; 29(1 Suppl 64):S23-34. PubMed ID: 21470488
[TBL] [Abstract][Full Text] [Related]
10. Mepolizumab as a steroid-sparing treatment option in patients with Churg-Strauss syndrome.
Kim S; Marigowda G; Oren E; Israel E; Wechsler ME
J Allergy Clin Immunol; 2010 Jun; 125(6):1336-43. PubMed ID: 20513524
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of the interleukin 5 receptor alpha isoforms in blood and tissue eosinophils of nasal polyp patients.
Gevaert P; Hellman C; Lundblad L; Lundahl J; Holtappels G; van Cauwenberge P; Tavernier J; Bachert C
Allergy; 2009 May; 64(5):725-32. PubMed ID: 19170670
[TBL] [Abstract][Full Text] [Related]
12. Apoptotic eosinophils in sputum from asthmatic patients correlate negatively with levels of IL-5 and eotaxin.
Xu J; Jiang F; Nayeri F; Zetterström O
Respir Med; 2007 Jul; 101(7):1447-54. PubMed ID: 17379492
[TBL] [Abstract][Full Text] [Related]
13. Sputum eosinophilia in Churg-Strauss syndrome.
Meziane H; Maakel ML; Vachier I; Bousquet J; Chanez P
Respir Med; 2001 Oct; 95(10):799-801. PubMed ID: 11601744
[TBL] [Abstract][Full Text] [Related]
14. Increased expression of TRAIL receptor 3 on eosinophils in Churg-Strauss syndrome.
Mitsuyama H; Matsuyama W; Watanabe M; Shirahama Y; Higashimoto I; Wada T; Osame M; Arimura K
Arthritis Rheum; 2007 Feb; 56(2):662-73. PubMed ID: 17265502
[TBL] [Abstract][Full Text] [Related]
15. A case of Churg-Strauss syndrome: flow cytometric analysis of the surface activation markers of peripheral eosinophils.
Nakahigashi K; Otsuka A; Miyachi Y; Kabashima K; Tanioka M
Acta Derm Venereol; 2013 Jan; 93(1):100-1. PubMed ID: 22688790
[No Abstract] [Full Text] [Related]
16. Involvement of soluble CD95 in Churg-Strauss syndrome.
Müschen M; Warskulat U; Perniok A; Even J; Moers C; Kismet B; Temizkan N; Simon D; Schneider M; Häussinger D
Am J Pathol; 1999 Sep; 155(3):915-25. PubMed ID: 10487849
[TBL] [Abstract][Full Text] [Related]
17. Churg-Strauss syndrome: serum markers of lymphocyte activation and endothelial damage.
Schmitt WH; Csernok E; Kobayashi S; Klinkenborg A; Reinhold-Keller E; Gross WL
Arthritis Rheum; 1998 Mar; 41(3):445-52. PubMed ID: 9506572
[TBL] [Abstract][Full Text] [Related]
18. Different regulation of eosinophil activity in Crohn's disease compared with ulcerative colitis.
Lampinen M; Backman M; Winqvist O; Rorsman F; Rönnblom A; Sangfelt P; Carlson M
J Leukoc Biol; 2008 Dec; 84(6):1392-9. PubMed ID: 18801925
[TBL] [Abstract][Full Text] [Related]
19. The common allergens in the Churg-Strauss syndrome.
Bottero P; Bonini M; Vecchio F; Grittini A; Patruno GM; Colombo B; Sinico RA
Allergy; 2007 Nov; 62(11):1288-94. PubMed ID: 17919144
[TBL] [Abstract][Full Text] [Related]
20. The proportion of regulatory T cells in the peripheral blood reflects the relapse or remission status of patients with Churg-Strauss syndrome.
Saito H; Tsurikisawa N; Tsuburai T; Oshikata C; Akiyama K
Int Arch Allergy Immunol; 2011; 155 Suppl 1():46-52. PubMed ID: 21646795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
